je.st
news
Tag: european
Sanofi's big new cholesterol drug wins European green light
2015-07-25 13:43:00| Biotech - Topix.net
A new type of cholesterol drug from Sanofi and Regeneron Pharmaceuticals won a green light from European regulators on Friday, two months behind a rival product from Amgen. The European Medicines Agency said its experts had recommended Praluent for patients unable to control their cholesterol despite taking optimal doses of conventional statin pills or those who cannot take statins.
Cargill Welcomes Clearance from European Commission for Purchase of ADM's Chocolate Business
2015-07-24 12:31:06| Industrial Newsroom - All News for Today
AMSTERDAM The European Commission has granted conditional clearance for Cargill to acquire Archer Daniels Midland's (NYSE: ADM) chocolate business in Europe. Together with the approvals granted earlier by the US Department of Justice, this completes the regulatory approval process for the global deal. "The...
Tags: business
purchase
european
commission
Vodafone's slow European recovery continues in fiscal Q1
2015-07-24 02:00:00| Total Telecom industry news
U.K.-based telco reports slim organic service revenue growth led by emerging market ops.
Tags: european
slow
continues
recovery
Nokia, ALU deal gets European OK
2015-07-24 02:00:00| Total Telecom industry news
European Commission clears vendor tie-up without conditions.
Merck Announces European Medicines Agency Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection
2015-07-23 17:02:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients with chronic hepatitis C (HCV) genotypes (GT) 1, 3, 4 or 6 infection.1 The EMA will initiate review of the MAA under accelerated assessment timelines. Language: English Contact: Merck & Co., Inc.Media:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
application
marketing
treatment
Sites : [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] next »